(Q36903693)

17 August 2017

1 reference

title

Optimizing drug exposure to minimize selection of antibiotic resistance (English)

1 reference

17 August 2017

antibiotic resistance

1 reference

Sara K Olofsson

1

1 reference

PubMed ID

17683017

17 August 2017

Otto Cars

series ordinal

2

1 reference

PubMed ID

17683017

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Clinical Infectious Diseases

17 August 2017

1 reference

17 August 2017

45 Suppl 2

1 reference

17 August 2017

S129-36

1 reference

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

17 August 2017

1 reference

Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance

21 January 2018

1 reference

Muller's ratchet decreases fitness of a DNA-based microbe

21 January 2018

1 reference

Hypermutable bacteria isolated from humans--a critical analysis

21 January 2018

1 reference

Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair

21 January 2018

1 reference

An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus

21 January 2018

1 reference

Mutator bacteria as a risk factor in treatment of infectious diseases

21 January 2018

1 reference

Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

21 January 2018

1 reference

Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage.

21 January 2018

1 reference

Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus

21 January 2018

1 reference

The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants.

21 January 2018

1 reference

Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance

21 January 2018

1 reference

The biological cost of antibiotic resistance

21 January 2018

1 reference

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers

21 January 2018

1 reference

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

Fitness cost of chromosomal drug resistance-conferring mutations

21 January 2018

1 reference

Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori

21 January 2018

1 reference

Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin

21 January 2018

1 reference

Virulence of antibiotic-resistant Salmonella typhimurium

21 January 2018

1 reference

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

21 January 2018

1 reference

Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection

21 January 2018

1 reference

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo i

21 January 2018

1 reference

The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs

21 January 2018

1 reference

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

21 January 2018

1 reference

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance

21 January 2018

1 reference

Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.

21 January 2018

1 reference

Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs

21 January 2018

1 reference

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

21 January 2018

1 reference

Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing

21 January 2018

1 reference

In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model

21 January 2018

1 reference

Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model

21 January 2018

1 reference

Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli

21 January 2018

1 reference

Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model

21 January 2018

1 reference

In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations

21 January 2018

1 reference

Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies

21 January 2018

1 reference

Mutant selection window hypothesis updated.

21 January 2018

1 reference

Antimicrobial drug use and resistance among respiratory pathogens in the community

21 January 2018

1 reference

Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli

21 January 2018

1 reference

Low correlation between MIC and mutant prevention concentration

21 January 2018

1 reference

Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates

21 January 2018

1 reference

Stretching the mutant prevention concentration (MPC) beyond its limits

21 January 2018

1 reference

The mutant selection window and antimicrobial resistance

21 January 2018

1 reference

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model

21 January 2018

1 reference

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

21 January 2018

1 reference

The mutant selection window in rabbits infected with Staphylococcus aureus.

21 January 2018

1 reference

Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.

21 January 2018

1 reference

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/519256

1 reference

17 August 2017

1 reference

PubMed ID

17683017